Mendus AB (publ) announces Q4 and year-end results 2022

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Mendus AB (publ) announces Q4 and year-end results 2022
 8:00:00 AM

Keep reading
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meetingRead